Hanugen Therapeutics Private Limited, a active private limited company, was established on 20 February 2017 in Bangalore North, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73200KA2017PTC100686. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Arun Shastry (Director), Manjulam (Director), Rav Deep Singh Anand (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 7, Balaji Arcade, 3Rd Floor, Chikkamaranahalli,, Opp Hp Petrol Bunk, New Bel Road,, Bangalore North, Karnataka, 560094.
U73200KA2017PTC100686
100686
20 February 2017
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hanugen Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Shastry | Director | 20 Feb 2017 | Current |
| Manjulam | Director | 20 Feb 2017 | Current |
| Rav Deep Singh Anand | Director | 20 Feb 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hanugen Therapeutics Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.32% decrease. The company also saw a substantial improvement in profitability, with a 22.9% increase in profit. The company's net worth Soared by an impressive increase of 43.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Hanugen Therapeutics had a promoter holding of 90.83% and a public holding of 9.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hanugen Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hanugen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hanugen Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hanugen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Hanugen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on Arun Shastry was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 8 years 9 months . was documented.
Progress on Manjulam was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 8 years 9 months . was documented.
Rav Deep Singh Anand was appointed as a Director was appointed as a Director on 20 Feb 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The activity Hanugen Therapeutics Private Limited was registered on 20 Feb 2017 with Roc Bangalore & aged 8 years 9 months as per MCA records. was completed.
The CIN of Hanugen Therapeutics Private Limited is U73200KA2017PTC100686.
Hanugen Therapeutics Private Limited is headquartered at No. 7, Balaji Arcade, 3Rd Floor, Chikkamaranahalli,, Opp Hp Petrol Bunk, New Bel Road,, Bangalore North, Karnataka, 560094.
Hanugen Therapeutics Private Limited was incorporated on 20 February 2017.
The current directors of Hanugen Therapeutics Private Limited are
The primary industry of Hanugen Therapeutics Private Limited is Professional, Scientific And Technical.
Hanugen Therapeutics Private Limited is unlisted.
The authorized capital of Hanugen Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Hanugen Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX